| [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|-----|-----------------------------------------------------------------------------------------|

| CALIFORNIA                                 | 333-29295                         | 95-4298051                    |
|------------------------------------------------------|-----------------------------------|-------------------------------|
| (State of incorporation or organization)   | (Commission File No.)   | (I.R.S. Identification Number |
|                                                                              |
|-----------------------------------------------------------------------------------|
| Former name, former address, and former fiscal year, if changed since last report |
| Large accelerated filer  [_]                                                        |   | Accelerated filer  [_]         |
|-------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------|
| Non-accelerated filer   [_] (Do not check if a smaller reporting company)      |   | Smaller reporting company  [X] |

----

|                                 |                                                                                                                                                                                                 |
|--------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                 |                                                                                                                                                                                                 |  |   |
| Part I - FINANCIAL INFORMATION  |                                                                                                                                                                                                 | Page |   |
| Item 1.                              | Financial Statements                                                                                                                                                                                 |   |  |   |
|                                 | Balance Sheets as of June 30, 2016 (unaudited) and December 31, 2015 (unaudited)                                                                                                           |   |   | 2 |   |
|                                      | Statements of Operations (unaudited) for the three and six months ended June 30, 2016 and 2015, and for the Development Period from October 11, 2006 to June 30, 2016.      |   |  | 3 |   |
|                                 | Statements of Cash Flows (unaudited) for the six months ended June 30, 2016 and 2015,  and for the Development Period from October 11, 2006 to June 30, 2016                          |   |   | 5 |   |
|                                 | Notes to Financial Statements (unaudited)                                                                                                                                                            |   |   | 6 |   |
| Item 2.                              | Management's Discussion and Analysis or Plan of Operation                                                                                                                                            |   |   | 11 |   |
| Item 3.                              | Quantitative and Qualitative Disclosures About Market Risk                                                                                                                                           |   |   | 13 |   |
| Item 4.                              | Controls and Procedures                                                                                                                                                                              |   |   | 13 |   |
|                                 |                                                                                                                                                                                                 |   |   |   |   |
| Part II - OTHER INFORMATION          |                                                                                                                                                                                                 |   |   |   |
| Item 1.                              | Legal Proceedings                                                                                                                                                                                    |   |   | 14 |   |
| Item 1A.                             | Risk Factors                                                                                                                                                                                         |   |   | 14 |   |
| Item 2.                              | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                                          |   |   | 14 |   |
| Item 3.                              | Defaults Upon Senior Securities                                                                                                                                                                      |   |   | 14 |   |
| Item 4.                              | Mine Safety Disclosures                                                                                                                                                                              |   |   | 14 |   |
| Item 5.                              | Other Information                                                                                                                                                                                    |   |   | 14 |   |
| Item 6.                              | Exhibits                                                                                                                                                                                             |   |   | 14 |   |
| SIGNATURES                           |                                                                                                                                                                                                 |   | 15 |   |

----

|                                                         |   | June 30, 2016 |       |   | December 31, 2015 |   |
|--------------------------------------------------------------|--------|---------------|------------|--------|-------------------|--------|
|                                               |   | (Unaudited)   |       |   | (Unaudited)       |   |
| ASSETS                                                       |   |               |       |   |                   |   |
|                                                         |   |               |       |   |                   |   |
| Current assets:                                              |   |               |       |   |                   |   |
| Cash                                                         |   |               |       |   |              | 0      |   |
| Total current assets                                         |   | $             | -          |   |              | $      | - |   |
|                                                         |   |          |       |   |              |   |   |   |
|                                                         |   |          |       |   |              |   |   |   |
|                                                         |   |          |       |   |              |   |   |   |
|                                                         |   |          |       |   |              |   |   |   |
| LIABILITIES AND STOCKHOLDERS' (DEFICIT)                      |   |          |       |   |              |   |   |   |
|                                                         |   |          |       |   |              |   |   |   |
| Current liabilities:                                         |   |          |       |   |              |   |   |   |
| Accounts payable                                             |   | $             | 2,889      |   |              | $      | 3,904 |   |
| Accrued expenses                                             |   |          | 3,775      |   |              |   | 3,375 |   |
| Advances payable - officer                                   |   |          | 6,934      |   |              |   | 6,934 |   |
| Notes payable - stockholders                                 |   |          | 198,266    |   |              |   | 198,266 |   |
| Accrued interest - stockholders                              |   |          | 114,245    |   |              |   | 106,336 |   |
| Total current liabilities                                    |   |          | 326,109    |   |              |   | 318,815 |   |
|                                                         |   |          |       |   |              |   |   |   |
| Commitments and contingencies (Notes 1, 2, 3, and 5)         |   |          |       |   |              |   |   |   |
|                                                         |   |          |       |   |              |   |   |   |
| Stockholders' (deficit):                                     |   |          |       |   |              |   |   |   |
| Preferred stock - no par value, authorized 1,000,000 shares: |   |          |       |   |              |   |   |   |
| No shares issued or outstanding                              |   |          | -          |   |              |   | - |   |
| Common stock - no par value, 100,000,000 shares authorized:  |   |          |       |   |              |   |   |   |
| 14,425,903 shares issued and outstanding                     |   |          | 6,903,766  |   |              |   | 6,903,766 |   |
| Additional paid-in capital                                   |   |          | 239,866    |   |              |   | 235,873 |   |
| Accumulated deficit through October 11, 2006                 |   |          | (7,302,235 | )      |              |   | (7,302,235 | ) |
| (Accumulated deficit) during development stage               |   |          | (167,506   | )      |              |   | (156,219 | ) |
| Total stockholders' (deficit)                                |   |          | (326,109   | )      |              |   | (318,815 | ) |
|                                                         |   |          |       |   |              |   |   |   |
| Total liabilities and stockholders' (deficit)                |   | $             | (0         | )      |              | $      | 0.00 |   |

----

|                                 |   |        |       |   |        |   |       |
|--------------------------------------|--------|--------|------------|--------|--------|--------|------------|
|                                 |   |        |       |   |        |   |       |
|                                 |   | 2016   |       |   | 2015   |   |       |
|                                 |   |        |       |   |        |   |       |
|                                 |   |        |       |   |        |   |       |
| Revenues                             |   | $      | -          |   |   | $      | -          |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Expenses:                            |   |   |       |   |   |   |       |   |   |
| General and administrative:          |   |   |       |   |   |   |       |   |   |
| Financing costs                      |   |   | -          |   |   |   | -          |   |   |
| Consulting fees                      |   |   | -          |   |   |   | -          |   |   |
| Accounting and legal                 |   |   | 525        |   |   |   | 450        |   |   |
| Investor relations                   |   |   | 633        |   |   |   | 484        |   |   |
| Total expenses                       |   |   | 1,158      |   |   |   | 934        |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Operating (loss)                     |   |   | (1,158     | )      |   |   | (934       | ) |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Other income (expense):              |   |   |       |   |   |   |       |   |   |
| Gain from litigation settlement      |   |   | -          |   |   |   | -          |   |   |
| Interest (expense)                   |   |   | (3,954     | )      |   |   | (3,954     | ) |   |
|                                 |   |   | (3,954     | )      |   |   | (3,954     | ) |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Income (loss) before income taxes    |   |   | (5,112     | )      |   |   | (4,888     | ) |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Provision for income taxes           |   |   | 200        |   |   |   | 200        |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Net income (loss)                    |   | $      | (5,312     | )      |   | $      | (5,088     | ) |   |
|                                 |   |   |       |   |   |   |       |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Net (loss) per common share:         |   |   |       |   |   |   |       |   |   |
| Basic and Diluted                    |   | $      | Nil   |   |   | $      |  Nil  |   |   |
|                                 |   |   |       |   |   |   |       |   |   |
| Weighted average shares outstanding: |   |   |       |   |   |   |
| Basic and Diluted                    |   |   | 14,425,903 |   |   |   | 14,425,903 |   |   |

----

|                                 |   |        |       |   |        |   |       | Development Period |   |
|--------------------------------------|--------|--------|------------|--------|--------|--------|------------|--------------------|--------|
|                                 |   |        |       |   |        |   |       | October 11, 2006   |   |
|                                 |   | 2016   |       |   | 2015   |   |       | to June 30, 2016   |   |
|                                 |   |        |       |   |        |   |       |                    |   |
|                                 |   |        |       |   |        |   |       |                    |   |
| Revenues                             |   | $      | -          |   |   | $      | -          |               |   | $ | - |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Expenses:                            |   |   |       |   |   |   |       |               |   |   |   |   |
| General and administrative:          |   |   |       |   |   |   |       |               |   |   | - |   |
| Financing costs                      |   |   | -          |   |   |   | -          |               |   |   | 2,917 |   |
| Consulting fees                      |   |   | -          |   |   |   | -          |               |   |   | 8,029 |   |
| Accounting and legal                 |   |   | 1,050      |   |   |   | 900        |               |   |   | 128,598 |   |
| Investor relations                   |   |   | 1,928      |   |   |   | 894        |               |   |   | 42,974 |   |
| Total expenses                       |   |   | 2,978      |   |   |   | 1,794      |               |   |   | 182,518 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Operating (loss)                     |   |   | (2,9       | )      |   |   | (1,794     | )                  |   |   | (182,518 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Other income (expense):              |   |   |       |   |   |   |       |               |   |   |   |   |
| Gain from litigation settlement      |   |   | -          |   |   |   | -          |               |   |   | 137,310 |   |
| Interest (expense)                   |   |   | (7,909     | )      |   |   | (7,866     | )                  |   |   | (114,245 | ) |
|                                 |   |   | (7,909     | )      |   |   | (7,866     | )                  |   |   | 23,065 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Income (loss) before income taxes    |   |   | (10,887    | )      |   |   | (9,660     | )                  |   |   | (159,453 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Provision for income taxes           |   |   | 400        |   |   |   | 400        |               |   |   | 8,190 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Net income (loss)                    |   | $      | (11,287    | )      |   | $      | (10,060    | )                  |   | $ | (167,643 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Net (loss) per common share:         |   |   |       |   |   |   |       |               |   |   |   |   |
| Basic and Diluted                    |   | $Nil   |       |   | $Nil   |   |       | $Nil               |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Weighted average shares outstanding: |   |   |       |   |   |   |       |               |   |
| Basic and Diluted                    |   |   | 14,425,903 |   |   |   | 14,425,903 |               |   |   |   |   |

----

|                                                   |   |        |    |   |        |   |    |                    |   |
|--------------------------------------------------------|--------|--------|---------|--------|--------|--------|---------|--------------------|--------|
|                                                   |   |        |    |   |        |   |    | Development Period |   |
|                                                   |   |        |    |   |        |   |    | October 11, 2006   |   |
|                                                   |   | 2016   |    |   | 2015   |   |    | to June 30, 2016   |   |
|                                                   |   |        |    |   |        |   |    |                    |   |
|  Cash flows from operating activities:            |   |        |    |   |        |   |    |                    |   |
|  Net income (loss)                                |   | $      | (11,287 | )      |   | $      | (10,059 | )                  |   | $ | (138,317 | ) |
| Adjustments to reconcile net income (loss) to net cash |   |   |    |   |   |   |    |               |   |
|  used by operating activities:                    |   |   |    |   |   |   |    |               |   |   |   |   |
|  Gain from litigation settlement                  |   |   |    |   |   |   |    |               |   |   | (137,310 | ) |
| Shares issued for loan fees and consulting fees        |   |   |    |   |   |   |    | 10,946             |   |
| Changes in operating assets and liabilities:           |   |   |    |   |   |   |    |               |   |
|  Accounts payable                                 |   |   | (1,015  | )      |   |   | 1,794   |               |   |   | (6,111 | ) |
|  Accrued expenses                                 |   |   | 400     |   |   |   | 400     |               |   |   | 3,300 |   |
|  Judgement payable                                |   |   |    |   |   |   |    |               |   |   | (27,750 | ) |
|  Accrued interest                                 |   |   | 7,909   |   |   |   | 7,865   |               |   |   | 95,544 |   |
|  Total adjustments                                |   |   | 7,294   |   |   |   | 10,059  |               |   |   | (61,381 | ) |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
| Net cash (used in) operating activities                |   |   | (3,993  | )      |   |   | -       |               |   |   | (199,698 | ) |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
|  Cash flows from investing activities:            |   |   |    |   |   |   |    |               |   |   |   |   |
| Net cash (used in) investing activities                |   |   | -       |   |   |   | -       |               |   |   | - |   |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
| Cash flows from financing activities:                  |   |   |    |   |   |   |    |               |   |   |   |   |
| Proceeds from notes payable - stockholders             |   |   |    |   |   |   |    | 182,898            |   |
| Cash Proceeds from add'l Paid in Capital               |   |   | 3,993   |   |   |   |    |               |   |   | 9,866 |   |
| Advances from officer                                  |   |   |    |   |   |   |    |               |   |   | 6,934 |   |
| Net cash provided by financing activities              |   |   | 3,993   |   |   |   | -       |               |   |   | 199,698 |   |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
| Net increase in cash and equivalents                   |   |   | -       |   |   |   | -       |               |   |   | - |   |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
| Cash and equivalents at beginning of year              |   |   | -       |   |   |   | -       |               |   |   | - |   |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
| Cash and equivalents at end of year                    |   | $      | -       |   |   | $      | -       |               |   | $ | - |   |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
|                                                   |   |   |    |   |   |   |    |               |   |   |   |   |
| Supplemental Cash Flow Information                     |   |   |    |   |   |   |    |               |   |   |   |   |
| Interest paid                                          |   | $      | -       |   |   | $      | -       |               |   | $ | - |   |
| Income taxes paid                                      |   | $      | -       |   |   | $      | -       |               |   | $ | 7,670 |   |

----

----

----

----

| Period Ending           |   | Estimated NOL Carry-forward |   | NOL Expires |   | Estimated Tax Benefit from NOL |   | Valuation Allowance |   | Change in Valuation Allowance | Net Tax Benefit |
|-------------------------|--------|-----------------------------|--------|-------------|--------|--------------------------------|--------|---------------------|--------|-------------------------------|-----------------|
| June 30, 2016           |   | $ 3,400                     |   | Various     |   | 700                            |   | (700)               |   | $(-0-)                        | $—        |
|  December 31, 2015 |   | 590,000                     |   | Various     |   | 133,000                        |   | (133,000)           |   | $(-0-)                        | $—        |

----

| Federal tax expense (benefit) at statutory rate |   |   | (15.00 | %) |
|-------------------------------------------------|--------|--------|--------|----|
| State tax expense (benefit), net of federal tax |   |   | (7.65  | %) |
| Deferred income tax valuation allowance         |   |   | 22.65  | %  |
| Reported tax rate                               |   |   | 0      | %  |

----

----

----

|  | · | The worldwide economic situation; |
|--|--------|-----------------------------------|

|  | · | Any change in interest rates or inflation; |
|--|--------|--------------------------------------------|

|  | · | The willingness and ability of third parties to honor their contractual commitments; |
|--|--------|--------------------------------------------------------------------------------------|

|  | · | Our ability to raise additional capital, as it may be affected by current conditions in the stock market and competition for risk capital; |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Environmental and other regulations, as the same presently exist and may hereafter be amended. |
|--|--------|------------------------------------------------------------------------------------------------|

----

|  | 31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic. |
|--|------|---------------------------------------------------------------------------------------------------|

|  | 32.1 | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic. |
|--|------|---------------------------------------------------------------------------------------------------|

|  | 101 | Interactive Data Files *To be filed by amendment |
|--|-----|--------------------------------------------------|

----

|                 | RETROSPETTIVA, INC |                                                                                 |
|----------------------|--------------------|--------------------------------------------------------------------------------------|
|                 |               |                                                                                 |   |
| Date:August 15, 2016 | By:                | /s/ Borivoje Vukadinovic                                                        |   |
|                 |               | Borivoje Vukadinovic, Director, Chief Executive Officer, and Chief Financial Officer |   |
|                 |               |                                                                                 |   |
|                 |               |                                                                                 |   |

----